Management and Customers Detail Four Strategic Themes, an AI-First Operating Model, a Clean Common-Stock Story, Compounding Free Cash Flow and a Proven Acquisition Engine
Rhea-AI Summary
CareCloud (Nasdaq: CCLD) used its May 19, 2026 Analyst Day to outline four growth themes: an AI-first platform, a simplified common-stock structure, rising free cash flow, and a disciplined acquisition strategy.
The company redeemed all remaining Series B preferred stock on May 15, 2026 using part of a $50 million credit facility, eliminating about $140 million of preferred equity and roughly $13.5 million in annual preferred dividends. Free cash flow has increased about six-fold since 2023, with 2026 guidance of approximately $25 million, and related principal and interest obligations expected to be less than half of that amount.
CareCloud highlighted AI tools such as its Stratus AI Front Desk Agent, which now autonomously handles about three of every four inbound patient calls. Since its 2014 IPO, the company has completed more than 20 tuck-in acquisitions. Customers including Fox Rehabilitation, KabaFusion, and The Lung Center reported improvements in denial rates, bad debt, claim resolution, chart completion, and call scheduling tied to CareCloud’s solutions.
Positive
- Eliminated approximately $140 million in preferred-equity overhang
- Removed about $13.5 million in annual preferred dividend obligations
- Guided to around $25 million in 2026 free cash flow
- Free cash flow up approximately six-fold since 2023
- Debt service expected to consume less than half of projected free cash flow
- More than 20 tuck-in acquisitions completed since 2014 IPO
- AI front desk agent handles roughly 75% of inbound patient calls autonomously
Negative
- $50 million credit facility introduces ongoing principal and interest payment obligations
News Market Reaction – CCLD
In the May 21 session, CCLD gained 0.85%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Acquisition,AI Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Sep 29 | AI-focused acquisition | Positive | +0.6% | Announced acquisition of HFMA’s MAP App to expand AI benchmarking tools. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
For AI/acquisition-themed news, CCLD has shown modest positive moves, with the prior tagged event posting a small gain, so today’s stronger rise stands out versus that history.
Over recent months, CareCloud has focused on simplifying its capital structure and emphasizing AI-driven growth. It reaffirmed guidance and detailed a $50M credit facility used to fully redeem Series B preferred stock, reported Q1 2026 results with continued AI product launches, and highlighted profitability and adjusted EBITDA guidance around $29–$31M. A prior acquisition,AI update on Sep 29, 2025 about HFMA’s MAP App produced a modestly positive reaction, providing context for today’s AI-first, cash-generative narrative.
Key Terms
credit facility financial
preferred stock financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOMERSET, N.J., May 21, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today provided a recap of its 2026 Analyst Day, held on May 19, 2026, at the Nasdaq MarketSite in Times Square, New York City. The event concluded with CareCloud ringing the Nasdaq Closing Bell in a ceremony broadcast live from Times Square.
Held under the theme “Building the AI-Native Healthcare Platform,” the Analyst Day brought together equity research analysts, investors, partners, and CareCloud customers for an in-depth look at the Company’s AI-driven product roadmap, financial performance, and growth strategy.
“Ringing the Nasdaq Closing Bell was a great way to cap a milestone day for CareCloud,” said Stephen Snyder, Chief Executive Officer of CareCloud. “We came to our Analyst Day with a clear and simple message: CareCloud is now an AI-first, profitable, and cash-generative company with a clean capital structure and a proven engine for growth. Having redeemed the last of our Series B Preferred Stock just days earlier, we were able to stand in front of our investors and customers as a fundamentally stronger company than at any point in our history.”
“One of the most meaningful aspects of our Analyst Day was having customers travel from across the country to join us on stage and share their experiences firsthand,” continued Snyder. “These are busy healthcare leaders who chose to spend their time with us because they believe in the value CareCloud delivers to their organizations. Hearing directly from Fox Rehabilitation, KabaFusion, and The Lung Center about the measurable clinical, operational, and financial results they have achieved is far more powerful than anything we could say ourselves. Their participation reflects the strength of our partnerships and reinforces our confidence in the long-term opportunity ahead.”
Four Strategic Themes
During the event, management highlighted four themes expected to drive CareCloud’s next phase of growth and value creation:
AI Is Fundamentally Reshaping Healthcare
Healthcare, a nearly
A Clean Common-Stock Story
With the full redemption of its remaining Series B Preferred Stock completed on May 15, 2026, funded through a portion of a
A Cash-Flow Compounder
CareCloud’s free cash flow has increased approximately six-fold since 2023, with 2026 guidance pointing to approximately
A Proven Acquisition Engine
With more than 20 tuck-in acquisitions completed since its 2014 IPO, CareCloud highlighted its disciplined acquisition strategy focused on recurring-revenue healthcare technology and services businesses. Management believes the Company’s growing cash flow provides increasing flexibility to pursue future acquisitions while maintaining financial discipline.
Customer Perspectives
A highlight of the Analyst Day was a series of presentations from three CareCloud customers who shared how the Company’s technology and services have supported their clinical, operational, and financial performance.
Fox Rehabilitation
Dr. Anthony Buccafurni, Chief Executive Officer of Fox Rehabilitation, discussed the company’s long-standing partnership with CareCloud and reported denial rates declining from over
KabaFusion
Dr. Sohail Masood, Chairman and Chief Executive Officer of KabaFusion, described how CareCloud helped scale the company’s revenue cycle operations and reported reducing bad debt from approximately
The Lung Center
Edsel P. Holden II, M.D., Founding Physician of The Lung Center, highlighted the benefits of CareCloud Cirrus AI and Stratus AI, reporting
A replay of the 2026 Analyst Day webcast, along with the accompanying investor presentation, will be available on May 22nd on the Company’s investor relations website at ir.carecloud.com.
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows, and improve the patient experience. More than 45,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM), and digital health, at carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases, and view the latest investor presentation, please visit ir.carecloud.com.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations, or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations regarding the Company’s strategic priorities and themes discussed at its 2026 Investor Analyst Day, its AI product roadmap and the adoption and performance of its AI products, expected future free cash flow generation, profitability, growth, acquisition strategy, the redemption of the Series B Preferred Stock and the related credit facility, and the expected results from the integration of past and future acquisitions. Past operational or stock price performance is not an indication of future performance.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain, and involve substantial known and unknown risks, uncertainties, and other factors which may cause our (or our industry’s) actual results, levels of activity, or performance to be materially different from any future results, levels of activity, or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, service the obligations under its credit facility, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact
Stephen Snyder
Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
